Thu, 03 Jan 2019 08:01:19 GMT
Sales of Johnson & Johnson's India drop 3% in 2017-2018
The US drugmaker Johnson & Johnson's sales in India plunged 3% in 2017-2018, ending March, as the company was battling with the stringent pricing policies on medical devices in the country.